Leukemia & Lymphoma Society: Translational Research Program

The LLS is accepting applications that are proposing novel approaches to the prevention, diagnosis or treatment of hematological malignancies and related pre-malignant conditions. Award amount is up to $600,000. Applicants must hold an MD or PhD, but do not have to be US citizens. LOI deadline is Jan. 25, 2016.

The UNC Office of Corporate and Foundation Relations has identified the following private funding opportunity:

Leukemia & Lymphoma Society - Translational Research Program
http://www.lls.org

The LLS is accepting applications that are proposing novel approaches to the prevention, diagnosis or treatment of hematological malignancies and related pre-malignant conditions. The TRP was developed to encourage and provide early-stage support for clinically translatable research in leukemia, lymphoma and myeloma, which is intended to develop innovative approaches to treatment, diagnosis or prevention. 

Applicants must hold an MD or PhD and do not have to be US citizens. Funding is limited to a maximum of $200,000, which includes direct costs and a maximum overhead of $19,982 or 11.1% of direct costs per year for three years. (That should equal $600,000 over three years). 

LOI Deadline: Jan. 25, 2016 by 3:00pm EST. Application guidelines are found here.

The UNC Office of Corporate and Foundation Relations is available to provide assistance in pursuing privately funded opportunities. Email cfr@unc.edu or phone 919-962-3423. 

Filed under: